Association of serology with the endovascular presence of Chlamydia pneumoniae and cytomegalovirus in coronary artery and vein graft disease

Circulation

Volumn 101, Issue 2, 2000, Pages 137-141

  Bartels, Claus ^a   Maass, Matthias ^a   Bein, Gregor ^b   Brill, Nicole ^a   Bechtel, J F Matthias ^a   Leyh, Rainer ^a   Sievers, Hans Hinrich ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Chlamydia pneumoniae; Coronary disease; Viruses

Indexed keywords

ANTIBODY; IMMUNOGLOBULIN G; INDICATOR;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CHLAMYDOPHILA PNEUMONIAE; CORONARY ARTERY DISEASE; CYTOMEGALOVIRUS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART DISEASE; HUMAN; IMMUNOFLUORESCENCE TEST; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; VEIN GRAFT;

EID: 0033962836     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.101.2.137     Document Type: Article

References (32)

1. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link? Lancet. 1997;350:430-436.
2. Libby P, Egan D, Skarlatos S. Roles of infectious agents in atherosclerosis and restenosis. Circulation. 1997;96:4095-4103.
3. Gurfinkel E, Bozovich G, Daroca A. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study. Lancet. 1997; 350:404-407.
4. Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and Azithromycin in male survivors of myocardial infarction. Circulation. 1997;96:404-407.
5. Grayston JT. Antibiotic treatment of Chlamydia pneumoniae for secondary prevention of cardiovascular events. Circulation. 1998;97: 1669-1670.
6. Bartels C, Maass M, Bein G, Brill N, Bechtel JFM, Leyh R, Sievers HH. Detection of Chlamydia pneumoniae but not cytomegalovirus in occluded saphenous vein coronary artery bypass grafts. Circulation. 1999;99: 879-882.
7. Maass M, Bartels C, Engel PM, Mamat U, Sievers HH. Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. J Am Coll Cardiol. 1998;31:827-832.
8. Kockx MM, Gambier BA, Bortier HE, Meyer GRD, Declercq SC. Foam cell replication and smooth muscle cell apoptosis in human saphenous vein grafts. Histopathology. 1994;25:365-371.
9. Maass M, Dalhotf K. Comparison of sample preparation methods for detection of Chlamydia pneumoniae in bronchoalveolar lavage fluid by PCR. J Clin Microbiol. 1994;32:2616-2619.
10. Bitsch A, Kirchner H, Dupke R, Bein G. Failure to detect human cytomegalovirus DNA in peripheral blood leukocytes of healthy blood donors by the polymerase chain reaction. Transfusion. 1992;32:612-617.
11. Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5′-3′-endonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA. 1991;88:7276-7280.
12. Heid CA, Stevens J, Livak KJ, Watson R. Real time quantitative PCR. Genome Res. 1996;6:986-994.
13. Lee LG, Connell CR, Bloch W. Allelic discrimination by nick-translation PCR with fluorogenic probes. Nucleic Acids Res. 1993;21:3761-3766.
14. Weiss SM, Roblin PM, Gaydos CA, Cummings P, Patton DL. Failure to detect Chlamydia pneumoniae in coronary atheromas of patients undergoing atherectomy. J Infect Dis. 1996;173:957-962.
15. Kuo C-C, Grayston JT, Campbell LA, Goo YA, Wissler RW, Benditt EP. Chlamydia pneumoniae (TWAR) in coronary arteries of young adults (15-34 years old). Proc Natl Acad Sci USA. 1995;92:6911-6914.
16. Jackson LA, Campbell LA, Schmidt RA, Kuo CC, Cappuccio AL, Lee M, Grayston JT. Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis. Am J Pathol. 1997;150:1785-1790.
17. Campbell LA. O'Brien ER, Cappucino AL, Kuo C-C, Wang S-P, Stewart D, Patton DL, Cummings PK, Grayston JT. Detection of Chlamydia pneumoniae TWAR in human coronary atherectomy tissues. J Infect Dis. 1995;172:585-588.
18. Muhlestein JB, Hammond E, Carlquist JF, Radicke E, Thomson MJ, Karagounis LA, Woods ML, Anderson JL. Increased incidence of chlamydia species within the coronary arteries of patients with symptomatic atherosclerotic versus other forms of cardiovascular disease. J Am Coll Card. 1996;27:1555-1561.
19. Wissler RW. Significance of Chlamydia pneumoniae (TWAR) in atherosclerotic lesions. Circulation. 1995;92:3376.
20. Puolakkainen M, Kuo C-C, Shor A, Wang S-P, Grayston JT, Campbell LA. Serological response to Chlamydia pneumoniae in adults with coronary arterial fatty streaks and fibrolipid plaques. J Clin Microbiol. 1993;31:2215-2217.
21. Blasi F, Denti F, Erba M, Cosentini R, Raccanelli R. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol. 1996;34:2766-2769.
22. Davidson M, Kuo C-C, Middaugh JP, Campbell LA, Wang S-P, Newman WP, Finley JC, Grayston JT. Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. Circulation. 1998;98:628-633.
23. Tiran A, Tio RA, Ossewaarde JM, Tiran B, Den Heijer P, The TH, Wilders-Truschnig MM. Coronary angioplasty induces rise in Chlamydia pneumoniae-specific antibodies. J Clin Microbiol. 1999;37:1013-1017.
24. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ. 1996;312:1061-1065.
25. Yamashiroya HM, Ghosh L, Yang R, Robertson AL. Herpesviridae in the coronary arteries and aorta of young trauma victims. Am J Pathol. 1988;130:71-79.
26. Melnick JL, Hu C, Burek J, Adam E, DeBakey ME. Cytomegalovirus DNA in arterial walls of patients with atherosclerosis. J Med Virol. 1994;42:170-174.
27. Hendrix MGR, Salimans MMM, van Bowen CPA, Bruggemannn CA. High Prevalence of latently present cytomegalovirus in arterial walls of patients suffering from grade III atherosclerosis. Am J Pathol. 1990;136:23-28.
28. Hendrix MGR, Dormans PHJ, Kitslaar P, Bosman F, Bruggemannn CA. The presence of cytomegalovirus nucleic acids in arterial wall of atherosclerotic and nonatherosclerotic patients. Am J Pathol. 1989;134: 1151-1157.
29. Benditt EP, Barrett T, McDougall JK. Viruses in the etiology of atherosclerosis. Proc Natl Acad Sci USA. 1983;80:6386-6389.
30. Kol A, Sperti G, Shani J, Schulhoff N, van de Greef W, Landini MP, La Placa M, Maseri A, Crea F. Cytomegalovirus replication is not a cause of instability in unstable angina. Circulation. 1995;91:1910-1913.
31. Manegold C, Alwazzeh M, Jablonski H, Adams O, Medve M, Seidlitz B, Heidland U, Häussinger D, Strauer B-E, Heintzen MP. Prior cytomegalovirus infection and the risk of restenosis after percutaneous transluminal coronary balloon angioplasty. Circulation. 1999;99:1290-1294.
32. Porter-Jordan K, Rosenberg EI, Keiser JF, Gross LD. Nested polymerase chain reaction assay for the detection of cytomegalovirus overcomes false positives caused by contamination with fragmented DNA. J Med Virol. 1990;30:85-91.